Intelligence Platform
Patents
Browse 68 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10385319
Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof
granted patentUS 10183080
Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of
granted patentUS 9687542
Rift valley fever virus replicon particles and use thereof
granted patentUS 9453239
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag a
granted patentUS 9079936
Derivatives of APF and methods of use
granted patentUS 8926987
Replication-competent adenoviral vectors
granted patentUS 8673292
Pure populations of astrocyte restricted precursor cells and methods for isolation and use
granted patentUS 8288359
Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
granted patentUS 8043623
Immunogenic peptides for the treatment of prostate and breast cancer
granted patentUS 7691386
Chimeric papillomavirus-like particles
granted patentUS 7402659
Thymic stromal lymphopoietin receptor molecules and uses thereof
granted patentUS 7311916
Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41
granted patentUS 7303751
Anti-plasmodium compositions and methods of use
granted patentUS 7303754
MVA expressing modified HIV envelope, gag, and pol genes
granted patentUS 7235232
Interferon alpha hybrids
granted patentUS 7235365
Specific binding agents for KSHV vIL-6 that neutralize a biological activity
granted patentUS 7045132
Streptococcus pneumoniae 37-kDa surface adhesin a protein
expired patentUS 7041498
Method for modulating processes mediated by farnesoid activated receptors
expired patentUS 6955895
Thymic stromal lymphopoietin receptor molecules and uses thereof
expired patentUS 6416957
Method for modulating process mediated by farnesoid activated receptors
expired